PRTA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.0M
-98.0%
51.1M
+243157.1%
21.0K
-99.1%
2.4M
-45.4%
4.4M
Cost of Revenue
0
0
0
0
0
Gross Profit
1.0M
-98.0%
51.1M
+243157.1%
21.0K
-99.1%
2.4M
-45.4%
4.4M
Operating Expenses
22.1M
+5.0%
21.0M
-13.1%
24.2M
-43.2%
42.7M
-52.1%
89.0M
R&D
8.8M
-30.3%
12.6M
-13.4%
14.6M
-49.6%
28.9M
-28.6%
40.5M
SG&A
10.9M
-14.0%
12.7M
+0.2%
12.6M
-4.5%
13.2M
-16.8%
15.9M
Operating Income
-21101000
-170.3%
30.0M
+224.1%
-24203000
+39.9%
-40240000
+52.4%
-84616000
EBITDA
-18490000
-171.2%
26.0M
+196.2%
-26993000
+31.7%
-39534000
+23.7%
-51782000
Net Income
-18583000
-156.8%
32.7M
+251.6%
-21589000
+40.9%
-36541000
+70.9%
-125767000
EPS (Basic)
$-0.36
-159.0%
$0.61
+252.5%
$-0.40
+41.2%
$-0.68
+70.9%
$-2.34
EPS (Diluted)
$-0.36
-160.0%
$0.60
+250.0%
$-0.40
+41.2%
$-0.68
+70.9%
$-2.34
Shares (Diluted)
52.1M
-3.6%
54.1M
+0.5%
53.8M
+0.0%
53.8M
+0.0%
53.8M
Prothena (PRTA) โ€” Financials